Silexion Therapeutics Corp (SLXN)

Price & Market Data

Price: $0.467

Daily Change: -$0.0077 / 1.65%

Daily Range: $0.42 - $0.51

Market Cap: $2,094,977

Daily Volume: 2,648,788

Performance Metrics

1 Week: 61.62%

1 Month: -53.29%

3 Months: -70.15%

6 Months: -81.33%

1 Year: -96.57%

YTD: -75.84%

About Silexion Therapeutics Corp (SLXN)

Summarized market data for Silexion Therapeutics Corp (SLXN). Price: 0.467, daily change: -$0.0077 / 1.65%. Market cap: 2,094,977. Performance over 3-month and 6-month periods.

Company Details

Employees: 14

Sector: Health technology

Industry: Pharmaceuticals: major

Country: Israel

Details

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.

Selected stocks

Aurelion Inc. (AURE)

J and Friends Holdings Limited (JF)

Angel Studios, Inc. (ANGX)

Atlantic International Corp. (ATLN)

SU Group Holdings Limited (SUGP)